Abstract
Epigenetic regulation plays an important role in oncogenesis. Histone modification is recognized as one strategy for modifying epigenetic control and cancer therapies. Cell culture and animal models show that protein arginine methyltransferase-5 (PRMT5) is an important epigenetic modifier of histone and nonhistone proteins in lymphomas, breast, colorectal, and lung cancer. Overexpression of PRMT5 is associated with malignant phenotype in …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
